Model
Edge
Amylyx Pharmaceuticals Inc.
0001969821
Filing Type
4
Filing Date
6/11/2023
Updated
6/12/23, 1:50 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership